| P50 | author | Sandro C. Esteves | Q38325634 |
| P2093 | author name string | Jatin Shah | |
| | Shweta Mittal Gupta | |
| | Soumyaroop Dash | |
| | Kundan Ingale | |
| | Milind Patil | |
| | Priti Thakor | |
| | Gautam Khastgir | |
| | Kshitiz Murdia | |
| | Durga G Rao | |
| | Kunji Moideen | |
| | Pavitra Dewda | |
| P2860 | cites work | Gonadotropin-releasing hormone analogs: Understanding advantages and limitations | Q27022451 |
| | Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones | Q28296995 |
| | Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins | Q28649708 |
| | Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. | Q30796722 |
| | GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis | Q33770533 |
| | High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study | Q33985728 |
| | Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. | Q34070191 |
| | Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis | Q34312003 |
| | The longer-term health outcomes for children born as a result of IVF treatment: Part I--General health outcomes | Q34330313 |
| | Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. | Q34355602 |
| | A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology | Q34875744 |
| | A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol | Q34997672 |
| | Two pathways of progesterone action in the human endometrium: implications for implantation and contraception | Q35605011 |
| | Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. | Q50646619 |
| | Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. | Q53547980 |
| | The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility | Q56852403 |
| | Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique? | Q61847446 |
| | Hormonal dynamics at midcycle: a reevaluation | Q70445378 |
| | Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles | Q71162571 |
| | Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen-thawed embryo transfer: a retrospective analysis | Q86382583 |
| | Freeze-all policy: fresh vs. frozen-thawed embryo transfer | Q86881041 |
| | Effect of preovulatory progesterone elevation and duration of progesterone elevation on the pregnancy rate of frozen-thawed embryo transfer in natural cycles | Q87410303 |
| | Progesterone and placental hormone actions on the uterus: insights from domestic animals | Q35671098 |
| | Selective single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy rates: a pre- and postintervention study | Q36477504 |
| | Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology? | Q36756209 |
| | Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis | Q37887020 |
| | Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles | Q38387639 |
| | Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders | Q38488249 |
| | Effects of perinatal, late foetal, and early embryonic insults on the cardiovascular phenotype in experimental animal models and humans | Q38947029 |
| | Serum progesterone trend after day of transfer predicts live birth in fresh IVF cycles | Q40382521 |
| | The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis | Q40817426 |
| | Endometrial preparation: lessons from oocyte donation | Q41240650 |
| | Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles | Q41585398 |
| | Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level. | Q41645094 |
| | Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism | Q42508805 |
| | A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. | Q42658780 |
| | Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis | Q42741040 |
| | Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles | Q43030787 |
| | Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer | Q43509083 |
| | Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials | Q43858225 |
| | Limitations of steroid determination by direct immunoassay. | Q43893236 |
| | Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos | Q43964590 |
| | Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in vitro fertilization | Q44083697 |
| | Limitations of direct estradiol and testosterone immunoassay kits | Q44672889 |
| | Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome | Q44687978 |
| | Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. | Q46020786 |
| | Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group | Q46319575 |
| | Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate | Q46413354 |
| | An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing h | Q46431371 |
| | Serum progesterone concentration on day of HCG administration and IVF outcome | Q46585501 |
| | Premature Progesterone Rise Positively Correlates with Clinical Pregnancy Rate in In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Patients with good Ovarian Response | Q47931970 |
| | Cryopreserved embryo transfer is an independent risk factor for placenta accreta | Q48583809 |
| | Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles | Q48651293 |
| | A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer | Q48657375 |
| | Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate | Q48785847 |
| | Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles | Q48787898 |
| | Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy | Q48949784 |
| | The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support | Q48983043 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 201 | |
| P577 | publication date | 2018-04-26 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles | |
| P478 | volume | 9 | |